Bridgebio Pharma, INC.
Medicines and investigational therapies for genetic conditions
Visit website ContactClaim & upgrade this listingContact details are protected Something wrong? Suggest a correction
BridgeBio Pharma develops medicines for patients with genetic conditions and other serious disorders. Its investigational pipeline targets transthyretin amyloidosis, muscular dystrophy, calcium regulation disorders, skeletal growth conditions and Canavan disease. The company reports three FDA approvals.
At a Glance
Bridgebio Pharma, INC. is an American manufacturer based in Palo Alto, CA.
- Where
- Palo Alto, CA
